Related by context. All words. (Click for frequent words.) 70 essential thrombocythemia ET 70 recurrent glioblastoma multiforme 69 polycythemia vera essential thrombocythemia 69 adalimumab Humira 69 Myelofibrosis 68 metastatic malignant 68 Initiate Clinical Trial 68 dual endothelin receptor antagonist 68 bacillus Calmette Guerin 68 CIMZIA TM certolizumab pegol 68 transplantation HCT 68 PEGylated Fab fragment 68 selective modulator 67 Relapsed Refractory 67 MGd 67 erythematosus 67 Aflibercept 67 Gleevec resistant 67 SNT-MC#/idebenone 67 Myelodysplastic Syndrome MDS 67 Kinoid 67 unresectable tumors 67 antibody MAb 67 idiopathic thrombocytopenic purpura 67 SPRYCEL ® 67 metastatic malignant melanoma 67 Myelodysplastic Syndrome 67 myelodysplastic myeloproliferative diseases 66 Achieves Primary Endpoint 66 PEGylated anti 66 sunitinib Sutent 66 idiopathic thrombocytopenic purpura ITP 66 leukemia AML 66 abacavir Ziagen 66 atypical hemolytic uremic syndrome 66 Hodgkin lymphoma HL 66 Pemphigus 66 denileukin diftitox 66 Atypical Hemolytic Uremic Syndrome 66 Vidaza azacitidine 66 thetreatment 66 cetuximab Erbitux ® 66 multiple myeloma MM 66 alpha1 antitrypsin deficiency 66 gastrointestinal stromal tumors GIST 66 gefitinib Iressa 66 non splenectomized 66 myeloproliferative disorder 66 ara C 66 allograft rejection 66 allogeneic hematopoietic cell 66 Cell Lymphoma 66 malignant ascites 66 Virologic 66 patientswith 66 lymphoid malignancies 65 cytomegalovirus infection 65 familial hypercholesterolemia FH 65 Lenalidomide 65 overactive bladder syndrome 65 fosbretabulin 65 purpura ITP 65 thalidomide Thalomid 65 Sipuleucel T 65 biliary tract cancer 65 trial evaluating PRX# 65 Philadelphia Chromosome Positive 65 achieved CCyR 65 hypereosinophilic syndrome 65 steroid refractory 65 allogeneic hematopoietic stem cell 65 Leber Hereditary Optic Neuropathy 65 Idiopathic Pulmonary Fibrosis 65 orally inhaled migraine 65 Epratuzumab 65 Pegylated Interferon 65 pretransplant 65 cell lymphoma CTCL 65 Initiates Clinical Trial 65 GW# [003] 65 sorafenib Nexavar 65 vapreotide acetate 65 ribavirin RBV 65 chronic eosinophilic leukemia 65 acetonide FA 65 verteporfin 65 SinuNase TM 65 Begins Dosing 65 treat chronic sinusitis 65 hA# 65 polycythemia vera PV 65 Ribavirin causes 65 taxane resistant 65 PEG IFN 65 idiopathic myelofibrosis 65 Tyrosine Kinase Inhibitor 65 Denufosol 65 demonstrated antitumor activity 65 null responder 65 systemic amyloidosis 65 pancreatic adenocarcinoma 65 Rituxan rituximab 65 Cimzia TM 65 Lupus Nephritis 65 Progressive Multifocal Leukoencephalopathy 65 Omacetaxine 65 Romiplostim 65 chronic thromboembolic pulmonary 65 Known hypersensitivity 64 Novel Oral 64 ANCA associated 64 NAVISTAR R 64 Anaplastic 64 Severe Sepsis 64 Diffuse Large B 64 TNF Tumor Necrosis Factor 64 Systemic Sclerosis 64 retinal vein occlusion induced 64 medically refractory 64 refractory chronic lymphocytic 64 Chronic Myelogenous Leukemia 64 gemcitabine Gemzar R 64 anthracyclines taxanes 64 Lymphocytic 64 recurrent glioblastoma 64 clevidipine 64 BCG refractory 64 MYLOTARG 64 Bosutinib 64 vidofludimus 64 CTAP# Capsules 64 colon carcinoma 64 generation purine nucleoside 64 dasatinib Sprycel 64 thyroid carcinoma 64 Heterozygous Familial Hypercholesterolemia 64 imatinib resistance 64 refractory acute myeloid 64 acute mania 64 GOUT 64 orally administered inhibitor 64 Alequel 64 Flu Cy 64 inhalation powder 64 Amgen Neulasta ® 64 cytogenetic abnormalities 64 immune thrombocytopenic purpura ITP 64 ORENCIA ® 64 adenomatous 64 gonococcal 64 Cryopyrin Associated Periodic Syndromes 64 previously untreated follicular 64 chronic granulomatous disease 64 antibody mediated 64 Pegloticase 64 Pharmacokinetics PK 64 metastatic neuroendocrine tumors 64 Oral Fingolimod 64 SSc 64 Naive Patients 64 immunomodulatory therapy 64 hepatic encephalopathy HE 64 Cutaneous T 64 Interferon beta 64 intranasal formulation 64 gastric adenocarcinoma 64 colorectal carcinoma 64 acute myeloid 64 haematologic 64 Improves Outcomes 64 intravascular hemolysis 64 antiphospholipid syndrome 64 Idiopathic Pulmonary Fibrosis IPF 64 estramustine 64 mutated KRAS 64 Temsirolimus 64 Multiple Myeloma MM 64 Hsp# Inhibitor 64 chronic myeloid 64 epithelial tumors 63 isoform selective 63 pan HDAC inhibitor 63 Phase 2b Clinical Trial 63 failure ADHF 63 Initiates Clinical 63 LHON 63 severe malignant osteopetrosis 63 leukoencephalopathy 63 colorectal cancer liver metastases 63 Microplasmin 63 Intravitreal 63 AA Amyloidosis 63 Nilotinib 63 Chronic lymphocytic leukemia 63 induced macular edema 63 refractory colorectal cancer 63 immune modulating 63 soluble tumor necrosis 63 Major Depressive Disorder MDD 63 Chronic Myelogenous Leukemia CML 63 LHRH receptor positive 63 thrombocytosis 63 Meets Primary Endpoint 63 Surgical resection 63 JAK2 inhibitor 63 MKC# MT 63 Chronic Myeloid Leukemia 63 complement inhibitor eculizumab 63 Dacogen decitabine 63 Graft Versus Host 63 bronchial hyperresponsiveness 63 undergoing hematopoietic stem 63 OHR/AVR# 63 recurrent glioblastoma multiforme GBM 63 Bucindolol 63 Phase #b/#a clinical 63 SYN# 63 Chronic Heart Failure 63 uremic pruritus 63 Patients Treated With 63 colorectal liver metastases 63 ADPKD 63 vaso occlusive crisis 63 Peripheral Arterial 63 kidney urologic 63 Cloretazine 63 5q deletion 63 Amgen Neulasta R 63 hyaluronidase enzyme 63 humanized monoclonal 63 arteritis 63 non metastatic osteosarcoma 63 either acutely decompensated 63 levodopa induced 63 etanercept Enbrel 63 beta 1a 63 Systemic Lupus Erythematosus SLE 63 Diabetic Macular Edema DME 63 TELINTRA R 63 MELAS 63 Enzastaurin 63 erythropoietic 63 Aptivus ® 63 nicardipine 63 Pegylated Liposomal Doxorubicin 63 Glioblastoma Multiforme 63 Peginterferon alfa 2b 63 psoriatic arthritis PsA 63 targeted nucleotide prodrug 63 Sprycel dasatinib 63 Glioblastoma Multiforme GBM 63 castrate resistant prostate cancer 63 chronic immune thrombocytopenic 63 5 fluorouracil leucovorin 63 Sudhir Agrawal D.Phil 63 Successfully Completes Phase 63 BrachySil TM 63 mesilate 63 pemphigus vulgaris 63 Occlusive Disease 63 FUSILEV enhances 63 Crohn disease CD 63 Ischemic 63 murine model 63 BARACLUDE ® 63 Acute Renal Failure 63 NS#/#A protease 63 neovascularisation 63 Chronic Myeloid Leukemia CML 63 Ph + acute lymphoblastic 63 glioblastoma multiforme GBM 63 ELACYT 63 mRCC 63 alfa 2a 63 elevated transaminases 63 fallopian tube carcinoma 63 HLA DR2 63 imatinib Gleevec ® 63 humanised monoclonal antibody 63 Refractory Hodgkin Lymphoma 63 thrombocytopenic 63 antiangiogenic therapy 63 lumiliximab 63 AGGRASTAT R Injection tirofiban 63 forodesine 63 hemorrhagic cystitis 63 p# biomarker 63 cetuximab Erbitux R 63 Investigational Treatment 63 bladder ovarian 63 eosinophilic asthma 63 cutaneous T 63 Shows Efficacy 63 relapsed MM 63 transthyretin amyloidosis 63 Prognostic factors 63 tumor lysis syndrome 63 Hedgehog Pathway Inhibitor 63 TTF Therapy 62 chronic rheumatic 62 receptor tyrosine kinase inhibitor 62 Diabetic Neuropathy 62 acute lymphoblastic 62 immunodeficiency disorders 62 Fabry Disease 62 Neovascular Age Related Macular 62 Parkinson Disease PD 62 genomic biomarker 62 imatinib Gleevec 62 CYT# potent vascular disrupting 62 K ras mutations 62 gastrointestinal stromal tumor GIST 62 hyperoxaluria 62 histone deacetylase HDAC inhibitor 62 Eculizumab 62 Safinamide 62 virally induced 62 post transplant lymphoproliferative 62 metastatic uveal melanoma 62 Juvenile Idiopathic Arthritis 62 CMV reactivation 62 PNP inhibitor 62 Familial Adenomatous Polyposis FAP 62 rituximab Rituxan 62 Factor VIIa 62 Kamada AAT 62 de novo kidney transplant 62 vasculopathy 62 bladder carcinoma 62 radiotherapy RT 62 5 FU leucovorin 62 erythematosus SLE 62 HeFH 62 Interferon Beta 62 mycosis fungoides 62 LymphoStat B belimumab 62 Initiates Phase II 62 basiliximab 62 targeted radiotherapeutic 62 irreversible inhibitor 62 Adjunctive 62 malignant lymphomas 62 adverse cytogenetics 62 Pemetrexed 62 rituximab refractory 62 esophageal gastric 62 squamous cell lung cancer 62 Hodgkin lymphoma NHL 62 Platinol ® 62 sipuleucel T 62 pulmonary alveolar 62 epoetin alpha 62 Unstable Angina 62 chills fever headache 62 Acute Ischemic Stroke 62 MyVax ® 62 PKC# 62 Prolongs Survival 62 gemcitabine Gemzar ® 62 hepatorenal syndrome 62 VitiGam 62 inhibitor RG# 62 Adult Stem Cell Therapy 62 small molecule tyrosine 62 HP Acthar Gel repository 62 pediatric Crohn disease 62 systemic anaplastic large 62 refractory prostate cancer 62 BrachySil ™ 62 refractory gout 62 Anti VEGF 62 alemtuzumab Campath 62 Intra arterial 62 anthracycline chemotherapy 62 tumors GIST 62 bleeding pallor 62 relapsing remitting MS RRMS 62 p# inhibitor 62 atypical Hemolytic Uremic Syndrome 62 Natalizumab 62 ZOLINZA 62 antibody mediated rejection 62 Interferon Alfa 62 hereditary emphysema 62 nephropathic cystinosis 62 hyperacute 62 deep venous thromboses 62 metastatic gastric 62 Intracoronary 62 Personalized Immunotherapy 62 ATTR CM 62 targeted antifolate 62 ACTEMRA TM 62 adjuvant cisplatin 62 Delayed Graft Function 62 bullous 62 docetaxel Taxotere ® 62 pouchitis 62 cytopenias 62 Doxil ® 62 riociguat 62 oral beclomethasone dipropionate 62 neovascular diseases 62 CTEPH 62 vinca alkaloid 62 investigational monoclonal antibody 62 hyperphenylalaninemia HPA due 62 transthyretin TTR mediated amyloidosis 62 immune thrombocytopenic purpura 62 Presents Preclinical Data 62 Hp2 2 62 Zarnestra 62 uricase 62 metastatic pancreatic 62 erlotinib Tarceva ® 62 ischemic mitral regurgitation 62 essential thrombocythemia 62 R lenalidomide 62 fallopian tube cancers 62 ORENCIA R 62 NASH Huntington 62 Diastolic Heart Failure 62 Squalamine 62 cystic fibrosis chronic pancreatitis 62 ® lenalidomide 62 p# MAP kinase inhibitor 62 NMIBC 62 dilated cardiomyopathy DCM 62 Files IND 62 cell carcinoma RCC 62 ductal adenocarcinoma 62 anagrelide 62 Nexavar sorafenib 62 fludarabine cyclophosphamide 62 interferon alpha IFN 62 relapsed refractory AML 62 EVIZON TM 62 hematological diseases 62 Metastatic Melanoma 62 Evoltra ® 62 acute peripheral arterial 62 B Cell Lymphoma 62 occlusion PAO 62 R entecavir 62 heparin induced thrombocytopenia 62 Chronic Bronchitis 62 Antitumor Activity 62 dyskeratosis congenita 62 mediated inhibition 62 CML CP 62 aripiprazole Abilify 62 pancytopenia 62 hematologic disorders 62 Hematologic 62 receiving immunosuppressive therapy 62 allogeneic bone marrow 62 efaproxiral 62 Aliskiren 62 receiving VELCADE 62 Diabetic nephropathy 62 interleukin IL -# 62 pediatric acute lymphoblastic 62 secondary hyperparathyroidism 62 mitoxantrone plus 62 aMCI precursor 61 subependymal giant cell 61 Copegus ribavirin 61 refractory anaplastic astrocytoma 61 recurrent GBM 61 TLK# 61 primary hyperparathyroidism 61 evaluating tivozanib 61 rhIGF-I/rhIGFBP-3 61 Demonstrates Significant 61 Allogeneic 61 cetuximab Erbitux 61 intratympanic 61 recombinant tissue plasminogen 61 INTEGRILIN R 61 mutated KRAS gene 61 Golimumab 61 severe oral mucositis 61 R Saizen R 61 haematologic malignancies 61 Motexafin Gadolinium 61 paraneoplastic 61 5 Fluorouracil 61 Myelodysplastic Syndromes 61 oral prodrug 61 demethylating agent 61 Lymphoid 61 Prosaptide 61 interstitial pneumonitis 61 induce orthostatic hypotension 61 Fondaparinux 61 Initiates Enrollment 61 Etanercept 61 tyrosine kinase inhibitors TKIs 61 Xelox 61 catheter occlusion 61 KRN# 61 Abrupt discontinuation 61 antifibrotic 61 toenail onychomycosis 61 cinacalcet 61 anticholinergic agents 61 invasive candidiasis 61 Relapsing Remitting Multiple Sclerosis 61 Diabetic Retinopathy DR 61 cisplatin gemcitabine 61 Acute myeloid leukemia AML 61 Tolvaptan 61 mild hepatic impairment 61 lintuzumab SGN 61 Chronic Sinusitis 61 treat benign prostatic 61 nonmetastatic 61 thymoma 61 mTOR mammalian target 61 progressive neurodegenerative 61 Neupogen ® 61 Gleevec imatinib mesylate 61 BRIM2 61 Factor Receptor 61 Myelodysplastic syndromes 61 steroid refractory ulcerative 61 nilotinib Tasigna 61 HDL Selective Delipidation 61 Carbamazepine 61 metastatic castration resistant 61 occlusion CRVO 61 demyelinating 61 ovarian carcinoma 61 pharmacokinetic PK study 61 systemic RNAi therapeutic 61 Genentech Rituxan 61 RNAi therapeutic targeting 61 infliximab Remicade 61 Bronchiectasis 61 Zybrestat 61 Vidaza ® 61 erythema nodosum 61 bevacizumab Avastin ® 61 administered intraperitoneally 61 sitaxsentan 61 Receives Orphan Drug Designation 61 gastric carcinoma 61 demyelinating disease 61 FOLOTYN ® 61 prostate adenocarcinoma 61 dasatinib Sprycel ® 61 Tumor Necrosis Factor 61 nucleotide analog 61 HLA DR4 61 Completes Patient Enrollment 61 Velcade bortezomib 61 potentially hepatotoxic 61 deletion 5q 61 vWD 61 Friedreich Ataxia FRDA 61 selective agonist 61 stable angina pectoris 61 immuno modulatory 61 undergoing liver transplantation 61 fistulizing Crohn disease 61 non nucleoside inhibitor 61 Selective inhibition 61 Upregulation 61 Cypher Sirolimus 61 Pivotal Study 61 pneumocystis carinii pneumonia 61 FOLFOX6 61 schizophrenia CIAS 61 smoldering myeloma 61 Complicated Skin 61 Vitrasert R 61 Hepatocellular Carcinoma 61 Leukemias 61 Subtypes 61 Neurofibromatosis type 61 pediatric pontine glioma 61 Paroxysmal Nocturnal Hemoglobinuria PNH 61 Shows Promise Against 61 thrombotic thrombocytopenic purpura 61 diabetes mellitus DM 61 NV1FGF 61 lymphoproliferative disorder 61 Percutaneous Transluminal Coronary Angioplasty 61 Elotuzumab 61 personalized dendritic cell 61 Parathyroid Hormone 61 endocrine therapies 61 HER2 overexpression 61 mGluR2 NAM 61 MOVIPREP R 61 Immunotherapeutic 61 sacral nerve stimulation 61 diabetic gastroparesis 61 symptomatic benign prostatic 61 Fingolimod 61 ischemia induced 61 Acute Decompensated Heart Failure 61 alefacept 61 de novo AML 61 CINTREDEKIN BESUDOTOX 61 phase IIb trial 61 Waldenstrom macroglobulinemia 61 Aviptadil 61 Hormone Refractory Prostate Cancer 61 topically administered 61 juvenile idiopathic arthritis 61 metastatic renal cell carcinoma 61 OMNARIS HFA 61 Inhalation Solution 61 transarterial 61 alkylating agent 61 IRX 2 61 EGFR TKI 61 MAGE A3 ASCI 61 IL# PE#QQR 61 oral anti arrhythmic 61 systemic mastocytosis 61 idiopathic PAH 61 Dasatinib 61 choroidal vasculopathy 61 myeloproliferative disease 61 autologous transplantation 61 transplantation HSCT 61 monoclonal antibody conjugated 61 Initiates Phase 2b 61 non resectable 61 investigational immunotherapy 61 liver decompensation 61 antiretroviral naïve 61 pancreatic carcinoma 61 IMA# 61 CMV infections 61 oxaliplatin Eloxatin 61 Campath alemtuzumab 61 symptomatic neurogenic orthostatic hypotension 61 papillary renal cell carcinoma 61 Luteinizing Hormone Releasing Hormone 61 Ferinject R 61 adult mesenchymal stem 61 Fulvestrant 61 infliximab etanercept 61 bone marrow reticulin deposition 61 CMV vaccine 61 ALN TTR 61 systemic lupus erythematosus SLE 61 Atopic Dermatitis 61 Bcr Abl T#I mutation 61 interstitial cystitis IC 61 PTLD 61 canakinumab 61 Lixivaptan 61 Non Alcoholic Fatty 61 adrenocortical cancer 61 aneurysms AAA 61 sarcomatoid 61 Radiofrequency Ablation RFA 61 antihypertensive therapies 61 Phase #/#a trial 61 KRAS oncogene 61 Alzheimer Disease AD 61 Actinic Keratosis 61 transcranial Doppler ultrasound 61 tubulin inhibitor 61 Idiopathic Thrombocytopenic Purpura ITP 61 Myoblast 61 gastrointestinal stromal tumors GISTs 61 Pafuramidine 61 pegylated liposomal doxorubicin 61 chimeric monoclonal antibody 61 symptomatic intracranial 61 HepaMate 61 stage IIIB 60 Neo Bladder Augment 60 NSAID induced 60 somatostatin analogue 60 Pegylated 60 myeloperoxidase 60 localized renal 60 Temodar temozolomide 60 Mutation Analysis 60 lymphomas leukemias 60 Roche Herceptin 60 Mycophenolate Mofetil 60 imatinib resistant 60 MYCN amplification 60 leukemia CML 60 myopathies 60 Angioedema 60 Xyfid TM 60 Novel Compound 60 imatinib therapy 60 Liprotamase 60 Dendritic Cell 60 Critical Limb Ischemia 60 Haptoglobin 60 completely resected 60 sJIA 60 Enzyme Replacement Therapy 60 Aplidin 60 Acute Myeloid Leukaemia AML 60 constipation OIC 60 neuroendocrine cancers 60 chemoresistant 60 prostate cancer CRPC 60 Monoclonal antibody 60 macular edema secondary 60 HBeAg positive patients 60 oropharyngeal candidiasis OPC 60 Morquio 60 intratumoral injection 60 neurogenic bladder 60 Osteopontin 60 leukemia ALL 60 metastatic GIST 60 Antiphospholipid Syndrome 60 treating neuropathic pain 60 coagulopathy 60 idiopathic pulmonary fibrosis IPF 60 acute humoral rejection 60 chronic myocardial ischemia 60 Ecallantide 60 recurrent herpes labialis 60 BH4 deficiency 60 PsA 60 Combination REOLYSIN R 60 Clolar ® 60 vinorelbine tartrate 60 Carbidopa 60 MTP inhibitor 60 Pulmonary Arterial Hypertension PAH 60 leukemia CLL 60 Chemotherapy Induced 60 efalizumab 60 enterococcal 60 Successfully Treats 60 visceral metastases 60 coagulation disorders 60 receptor inhibitor 60 idiopathic pulmonary arterial hypertension 60 Fludara ® 60 Preclinical Study 60 node metastasis 60 pulmonary hypertension PH 60 Impaired glucose tolerance 60 Orally administered 60 Panzem ® 60 Juvenile Idiopathic Arthritis JIA 60 Cytotoxic T 60 Acute Myelogenous Leukemia AML 60 VitiGam TM 60 Solid Tumours 60 Treanda bendamustine 60 Long Term Efficacy 60 hyperparathyroidism 60 Overactive Bladder 60 Systemic Lupus Erythematosus 60 G#DT 60 hypoxic tumors 60 8mg/kg 60 recurrent epithelial ovarian 60 pregabalin Lyrica 60 mGluR2 positive 60 NMDA antagonists 60 lichen planus 60 Progenitor Cells 60 Archexin 60 polyneuropathy CIDP 60 Gleevec Glivec 60 Drug Candidate 60 Gamunex C 60 VEGF induced 60 basal bolus regimen 60 haematological cancers 60 null responder HCV 60 TO AVOID PREGNANCY WHILE 60 circadian cytokine modulator 60 sorafenib tablets 60 Systemic lupus erythematosus SLE 60 urticaria hives 60 cytomegalovirus retinitis 60 allogeneic HSCT 60 KRAS mutant 60 topoisomerase II inhibitor 60 underwent resection 60 Reduces Mortality 60 Chemophase 60 Epstein Barr Virus 60 Degarelix 60 Trial Evaluating 60 primary immunodeficiency PI 60 Deforolimus 60 mild vasodilator 60 idebenone 60 cediranib 60 systemic fungal infections 60 XYOTAX TM 60 pT2 60 pathophysiological effects 60 lysosomal storage disease 60 biologic antibody 60 IMiDs ® 60 monoclonal anti 60 castrate resistant 60 Cell Lymphoma CTCL 60 Vascugel 60 acute GvHD 60 anemia thrombocytopenia 60 recurrent malignant glioma 60 autoimmune hemolytic anemia 60 Romidepsin 60 myeloproliferative 60 Adenoscan R 60 mastocytosis 60 telomerase inhibitor drug 60 Veno Occlusive Disease 60 esophageal candidiasis 60 Neulasta R 60 Myelodysplastic syndrome 60 IMiDs ® compound 60 refractory Hodgkin 60 thromboxane A2 60 relapsing multiple sclerosis 60 thalassemia sickle cell 60 phenothiazines 60 novel VDA molecule 60 plus gemcitabine 60 Interferon beta 1a 60 huC# DM4 60 cancer mCRC 60 ritonavir boosted 60 PEGylated interferon beta 1a 60 Certolizumab pegol 60 choroidal neovascularization 60 cholestasis 60 Noxafil 60 anterior uveitis 60 nimodipine 60 refractory cutaneous T 60 APPRAISE 60 Phase Ib IIa 60 oxypurinol 60 tiuxetan 60 PDX pralatrexate 60 TNF alpha selectively neutralizing 60 oral antidiabetic medication 60 FluCAM arm 60 Phase IIa Clinical Trial 60 advanced metastatic renal 60 reslizumab 60 intraepithelial neoplasia 60 IMiDs R 60 commercialize deforolimus 60 cardiometabolic diseases 60 metaglidasen 60 cardiac resynchronisation therapy 60 HERCEPTIN 60 Alport syndrome 60 Quinamed 60 YONDELIS R 60 treatmentof 60 TTR amyloidosis 60 Cannabinor 60 ADAMTS# 60 Initiate Phase 60 PYY #-# 60 carcinoid syndrome 60 gastrointestinal stromal tumor 60 HBeAg negative 60 Central Retinal Vein 60 AVAPRO 60 severe hypersensitivity reactions 60 invasive aspergillosis 60 hematopoietic cancers 60 Cotara ® 60 minimally symptomatic 60 chronic idiopathic 60 antithymocyte globulin 60 INCB# [003] 60 post herpetic neuralgia PHN 60 itraconazole Sporanox 60 chronic renal disease 60 Benign Prostatic Hyperplasia BPH 60 chronic idiopathic thrombocytopenic purpura 60 busulfan 60 Rheumatoid Arthritis RA 60 relapsed multiple myeloma 60 Eisenmenger syndrome 60 Alemtuzumab 60 pheochromocytoma 60 recombinant enzyme 60 Rheumatoid 60 metastatic colorectal 60 viral kinetics 60 unresectable HCC 60 interferon gamma 1b 60 cilengitide 60 YONDELIS 60 sapropterin dihydrochloride 60 dominantly inherited 60 Sezary syndrome 60 vWF 60 Kit CD# positive 60 Mitoxantrone 60 Morpholino 60 Tyrosine Kinase Inhibitors 60 Parathyroid hormone 60 HQK 60 Interstitial cystitis 60 Liposomal 60 recurrent metastatic 60 Phase 2b Trial 60 stem cell engraftment 60 adrenocortical carcinoma 60 cytogenic 60 INS# [001] 60 GRNCM1 60 Bisphosphonate 60 CRVO 60 Maribavir 60 pancreatic ductal adenocarcinoma 60 Zalypsis 60 cytopenia 60 neovascular 60 JAK2 V#F 60 KRAS status 60 Acute Myelogenous Leukemia 60 myoclonus 60 Janus kinase 60 monocytes macrophages 60 Acute Myeloid Leukemia 60 ribavirin therapy 60 acadesine 60 irinotecan chemotherapy 60 Efficacy Trial 60 Mitomycin C 60 reflux disease GERD 60 underlying vasculopathy 60 metastatic colorectal carcinoma 60 Alzheimer disease cognitive impairment 60 fluoropyrimidine 60 RezularTM 60 lung fibrosis 60 Malignant Glioma 60 symptomatic paroxysmal AF 60 anti angiogenic agents 60 CA9 SCAN 60 Xanafide 60 Oncolytic 60 potent antiproliferative 60 Roche MabThera 60 gastrointestinal perforation 60 cellular immunotherapy 60 QLT# 60 myasthenia gravis MG 60 locoregional disease 60 MPGN 60 Decitabine 60 stage IIIb IV 60 NAGS deficiency 60 BENLYSTA ® 60 pamidronate 59 Pralatrexate 59 CIMZIA R 59 autosomal dominant polycystic kidney 59 Clinically significant 59 Gleevec imatinib 59 included exfoliative dermatitis 59 Fludarabine 59 relapsed acute lymphoblastic 59 Preclinical Models 59 Respiratory Syncytial Virus RSV 59 T#I [002] 59 selective antagonist 59 Mantle Cell Lymphoma 59 inflammatory demyelinating 59 temozolomide Temodar 59 bortezomib Velcade 59 Shows Statistically Significant 59 antiangiogenic agent 59 liposomal formulation 59 Parnate 59 NSABP B 59 non splenectomised 59 Hypercholesterolemia 59 pancreatic ductal 59 Dacogen injection 59 Pegylated interferon 59 visilizumab 59 papillary thyroid carcinoma 59 arginine vasopressin AVP 59 interferon ribavirin 59 Nesiritide 59 HLA DR4 immune 59 idiopathic Parkinson disease